The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

References

• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• GroenewegenKH, ScholsAM, WoutersEF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459–467.12907529
   PubMed Web of Science ®Google Scholar
• CelliBR, ThomasNE, AndersonJA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178:332–338. doi:10.1164/rccm.200712-1869OC18511702
   PubMed Web of Science ®Google Scholar
• MakrisD, MoschandreasJ, DamianakiA, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med. 2007;101:1305–1312. doi:10.1016/j.rmed.2006.10.01217112715
   PubMed Web of Science ®Google Scholar
• PunekarYS, ShuklaA, MullerovaH. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis. 2014;9:65–73. doi:10.2147/COPD.S5441724426781
   PubMed Web of Science ®Google Scholar
• GuarascioAJ, RaySM, FinchCK, SelfTH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5:235–245.23818799
   PubMedGoogle Scholar
• MalinovschiA, Van MuylemA, MichielsS, MichilsA. FeNO as a predictor of asthma control improvement after starting inhaled steroid treatment. Nitric Oxide. 2014;40:110–116. doi:10.1016/j.niox.2014.06.00925014062
   PubMed Web of Science ®Google Scholar
• NeelameganR, SakaV, TamilarasuK, et al. Clinical utility of Fractional exhaled nitric oxide (FeNO) as a biomarker to predict severity of disease and response to Inhaled corticosteroid (ICS) in asthma patients. J Clin Diagn Res. 2016;10:FC01–FC06.
   PubMedGoogle Scholar
• PriceDB, BuhlR, ChanA, et al. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial. Lancet Respir Med. 2018;6:29–39. doi:10.1016/S2213-2600(17)30424-129108938
   PubMed Web of Science ®Google Scholar
• GaoJ, WuF. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma. Allergy Asthma Clin Immunol. 2018;14:21.29796021
   PubMed Web of Science ®Google Scholar
• GaoP, ZhangJ, HeX, et al. Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease. PLoS One. 2013;8:e57678. doi:10.1371/journal.pone.005767823741289
   PubMed Web of Science ®Google Scholar
• PascoeS, LocantoreN, DransfieldMT, BarnesNC, PavordID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3:435–442. doi:10.1016/S2213-2600(15)00106-X25878028
   PubMed Web of Science ®Google Scholar
• GaoJ, ZhangM, ZhouL, et al. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1287–1293. doi:10.2147/COPD.S13499828490872
   PubMed Web of Science ®Google Scholar
• VestboJ, AndersonW, CoxsonHO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J. 2008;31(4):869–873. doi:10.1183/09031936.0011170718216052
   PubMed Web of Science ®Google Scholar
• LiX, ZhouY, ChenS, et al. Early intervention with tiotropium in Chinese patients with GOLD stages I–II chronic obstructive pulmonary disease (Tie-COPD): study protocol for a multicentre, double-blinded, randomised, controlled trial. BMJ Open. 2014;4(2):e003991. doi:10.1136/bmjopen-2013-003991
   PubMed Web of Science ®Google Scholar
• AntusB, BartaI, HorvathI, CsiszerE. Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations. Respirology. 2010;15:472–477. doi:10.1111/j.1440-1843.2010.01711.x20210889
   PubMed Web of Science ®Google Scholar
• ZhouA, ZhouZ, PengY, et al. The role of CAT in evaluating the response to treatment of patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2018;13:2849–2858. doi:10.2147/COPD.S17508530237709
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma and Global Initiative for Chronic Obstructive Pulmonary Disease. Diagnosis and initial treatment of asthma, COPD, and asthma-COPD overlap. 2014 Available from: http://ginasthma.org. Accessed 95, 2020.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease(GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2017 Available from: http://goldcopd.org/. Accessed 95, 2020.
   Google Scholar
• JonesPW, HardingG, WiklundI, et al. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest. 2012;142(1):134–140. doi:10.1378/chest.11-030922281796
   PubMed Web of Science ®Google Scholar
• HossackT, WooH. Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy. Prostate Int. 2014;2(4):182–187. doi:10.12954/PI.1406625599074
   PubMedGoogle Scholar
• PossaSS, LeickEA, PradoCM, MartinsMA, TiberioIFLC. Eosinophilic inflammation in allergic asthma. Front Pharmacol. 2013;4:46. doi:10.3389/fphar.2013.0004623616768
   PubMed Web of Science ®Google Scholar
• VeriniM, ConsilvioNP, Di PilloS, et al. FeNO as a marker of airways inflammation: the possible implications in childhood asthma management. J Allergy (Cairo). 2010;2010.
   Google Scholar
• RaoDR, PhipatanakulW. An overview of fractional exhaled nitric oxide and children with asthma. Expert Rev Clin Immunol. 2016;12:521–530. doi:10.1586/1744666X.2016.114104926757849
   PubMed Web of Science ®Google Scholar
• ChenFJ, HuangXY, LiuYL, LinGP, XieCM. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2385–2390. doi:10.2147/COPD.S11537827713629
   PubMed Web of Science ®Google Scholar
• WuY-K, SuW-L, HuangC-Y, et al. Treatment of chronic obstructive pulmonary disease in patients with different fractional exhaled nitric oxide levels. Medicine (Baltimore). 2018;97(47):e11922. doi:10.1097/MD.000000000001192230461600
   PubMed Web of Science ®Google Scholar
• BhowmikA, SeemungalTA, DonaldsonGC, WedzichaJA. Effects of exacerbations and seasonality on exhaled nitric oxide in COPD. Eur Respir J. 2005;26:1009–1015. doi:10.1183/09031936.05.0004730516319329
   PubMed Web of Science ®Google Scholar
• AgustiAG, VillaverdeJM, TogoresB, BoschM. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 1999;14:523–528. doi:10.1034/j.1399-3003.1999.14c08.x10543270
   PubMed Web of Science ®Google Scholar
• Rio RamirezMT, Juretschke MoraguesMA, Fernandez GonzalezR, et al. Value of exhaled nitric oxide (FeNO) and eosinophilia during the exacerbations of chronic obstructive pulmonary disease requiring hospital admission. COPD. 2018;15:369–376. doi:10.1080/15412555.2018.148253230064275
   PubMedGoogle Scholar
• TashkinDP, WechslerME. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:335–349. doi:10.2147/COPD.S15229129403271
   PubMed Web of Science ®Google Scholar
• WuHX, ZhuoKQ, ChengDY. Peripheral blood eosinophil as a biomarker in outcomes of acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:3003–3015. doi:10.2147/COPD.S22678331920297
   PubMed Web of Science ®Google Scholar